SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
The Gamida Cell Ltd.-Teva Pharmaceutical Industries Limited Joint Venture Receives Green Light From the Data Monitoring Committee to Continue the Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma